Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Immunology
Fator do impacto: 1.404 FI de cinco anos: 3.347 SJR: 0.706 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimir: 1040-8401
ISSN On-line: 2162-6472

Volume 40, 2020 Volume 39, 2019 Volume 38, 2018 Volume 37, 2017 Volume 36, 2016 Volume 35, 2015 Volume 34, 2014 Volume 33, 2013 Volume 32, 2012 Volume 31, 2011 Volume 30, 2010 Volume 29, 2009 Volume 28, 2008 Volume 27, 2007 Volume 26, 2006 Volume 25, 2005 Volume 24, 2004 Volume 23, 2003 Volume 22, 2002 Volume 21, 2001 Volume 20, 2000 Volume 19, 1999 Volume 18, 1998 Volume 17, 1997 Volume 16, 1996 Volume 15, 1995 Volume 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v27.i4.10
pages 291-302

PART II. Toxins as Therapeutic Agents
Alpha-Cobratoxin as a Possible Therapy for Multiple Sclerosis: A Review of the Literature Leading to Its Development for This Application

Paul F. Reid
ReceptoPharm Inc., Plantation, FL 33313, USA


The use of snake venom in the treatment of multiple sclerosis has been, at best, controversial. The anecdotal reports for snake venom's beneficial effects in this condition may be supportable now by recent scientific evidence. Cobratoxin, a neurotoxin obtained from the venom of the Thailand cobra, has demonstrated several pharmacological activities that strongly support its use in this application. By employing a chemical detoxification step, the neurotoxin can be rendered safe for administration to humans with minimal side effects. This modified neurotoxin has demonstrated neuromodulatory, antiviral, and analgesic activity, elements associated with the multiple sclerosis condition. Modified cobratoxin has demonstrated potent immunosuppressive activity in acute and chronic animal models of the disease. The drug is under investigation for use in adrenomyeloneuropathy and clinical trials in Multiple sclerosis are planned.

Articles with similar content:

Exercise to Manage MS Fatigue: Counterintuitive Yet Effective
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.27, 2015, issue 2-4
A. V. Caprariello, K. M. Othonos, S. F. Kornfeld, Audrey L. Hicks
Development of Indian HIV-1 Subtype C Vaccine Candidates
Forum on Immunopathological Diseases and Therapeutics, Vol.6, 2015, issue 1-2
Swati Seth Yadav, Pradeep Seth
Interventional Pain Management: An Appraisal and Evidence-based Review
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.23, 2011, issue 1-4
Monalyce Hamza, Audra Eason, Timothy Reis, Maged Hamza, Andrew Medvadovsky, Mauna Radahd
Chronopharmacology: Appraising the Influence of Biorhythms on the Efficacy and Safety of Antihypertensive Drugs
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 6
Ammara Saleem, Uzma Saleem, Shafa Iman, Muhammad Furqan Akhtar, Fareeha Anwar, Bashir Ahmad
Cinnamomum zeylanicum (Darchini): A Boon to Medical Science and a Possible Therapy for Stress-Induced Ailments
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 3
Zulfia Hussain, Haroon Rashid, Junaid Ali Khan